Wire · opportunities
Answers to 3 questions about a potential Lyme vaccine
◆ Sectors
Health
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 28 August 2026 · Fusion42 review
Pfizer and Valneva have completed clinical trials for a Lyme vaccine and plan to submit it for FDA approval, but regulatory delays linked to changes in the CDC vaccine advisory committee may slow rollout in the US.
This Wire brief sits within Fusion42's coverage of Health.
◆ ◆ The Wire takeaway
You face a regulatory bottleneck for new vaccines in the US due to CDC advisory committee upheaval. Act now to navigate slower approval timelines and engage early with public health authorities.
◆ Coverage
1 source · 28 Aug 2026
◆ Related on Wire
◆ Topics
Healthlyme-diseasevaccine-developmentregulatory-delaypfizercdc